考虑胚胎发育速度的定制胚胎移植以克服个体化胚胎移植的困境
本研究回顾性比较了741例经子宫内膜容受性检测判定为容受期的反复种植失败患者,在激素替代周期中分别接受标准个体化胚胎移植或考虑胚胎发育速度的定制胚胎移植后的妊娠结局。倾向性评分匹配分析显示,定制胚胎移植组的临床妊娠率显著高于标准个体化胚胎移植组(P=0.014),但两组活产率相似(P=0.65)。在整倍体胚胎移植的亚组分析中,定制胚胎移植组的临床妊娠率显著更高(P=0.045),而活产率无差异(P=0.057)。作者认为,对于反复种植失败且经子宫内膜容受性检测判定为容受期的患者,后续采用定制胚胎移植策略可能进一步改善妊娠结局。
要点
- 在反复种植失败且经子宫内膜容受性检测判定为容受期的患者中,考虑胚胎发育速度的定制胚胎移植组临床妊娠率显著高于标准个体化胚胎移植组(P=0.014)。
- 两组活产率相似(P=0.65),整倍体胚胎移植亚组中定制胚胎移植组临床妊娠率显著更高(P=0.045),活产率无差异(P=0.057)。
- 作者认为,对于此类患者,后续定制胚胎移植策略可能进一步改善妊娠结局。
核心结论
- 对于反复种植失败且经子宫内膜容受性检测判定为容受期的患者,后续定制胚胎移植策略可能进一步改善妊娠结局。
研究设计与样本
- 回顾性比较了741例经子宫内膜容受性检测判定为容受期的患者,在激素替代治疗周期中分别接受标准个体化胚胎移植或定制胚胎移植。
主要发现
- 倾向性评分匹配分析显示,定制胚胎移植组临床妊娠率显著高于标准个体化胚胎移植组(P=0.014),两组活产率相似(P=0.65)。
- 整倍体胚胎移植亚组分析中,定制胚胎移植组临床妊娠率显著高于标准个体化胚胎移植组(P=0.045),两组活产率无差异(P=0.057)。
关键数值与推荐
- 定制胚胎移植根据每位患者既往胚胎发育模式估算复温囊胚的扩张等级,设定移植日使估算囊胚等级3、4、5、6分别于P+5、P+5.5、P+6.0、P+6.5天移植。
临床怎么用
- 对于反复种植失败且经子宫内膜容受性检测判定为容受期的患者,作者认为后续定制胚胎移植策略可能进一步改善妊娠结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does tailor-made embryo transfer (TmET), timed with respect to embryonic developmental speed, affect pregnancy outcomes in patients with recurrent implantation failure? DESIGN: Among 741 patients identified as receptive through endometrial receptivity testing, the clinical pregnancy rates and live birth rates were retrospectively compared between those who underwent standard personalized embryo transfer and those who underwent TmET in hormone replacement therapy cycles. Personalized embryo transfer was performed according to endometrial receptivity test results (standard personalized embryo transfer group) or considering embryonic developmental speed (TmET group). For TmET, the expansion grade of warmed blastocysts was estimated based on each patient's previous embryonic developmental pattern. The embryo transfer days were set so that estimated blastocyst grades 3, 4, 5 and 6 were transferred on days P+5, P+5.5, P+6.0 and P+6.5, respectively. RESULTS: In a propensity score matching analysis, the clinical pregnancy rate was significantly higher in the TmET group than the standard personalized embryo transfer group (P = 0.014), whereas the live birth rates were similar between the two groups (P = 0.65). In a subgroup analysis with euploid embryo transfers, the clinical pregnancy rate was significantly higher in the TmET group than the standard personalized embryo transfer group, although there was no difference in live birth rate between the two groups (P = 0.045 and P = 0.057, respectively). CONCLUSIONS: For patients experiencing recurrent implantation failure and identified as receptive through endometrial receptivity testing, subsequent TmET strategies may further enhance pregnancy outcomes.
引用
- Ohara Y, Matsubayashi H, Mizuta S, et al. Tailor-made embryo transfer considering embryonic developmental speed to overcome the dilemma of personalized embryo transfer. Reprod Biomed Online. 2024. PMID: 39562189. doi:10.1016/j.rbmo.2024.104405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。